Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dexamethasone 1mg

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dexamethasone 0.5mg

Israel - English - Ministry of Health

dexcel ltd, israel - chlorpheniramine maleate; dextromethorphan hydrobromide; paracetamol; pseudoephedrine hydrochloride - caplets - paracetamol 500 mg; chlorpheniramine maleate 2 mg; dextromethorphan hydrobromide 10 mg; pseudoephedrine hydrochloride 25 mg - pseudoephedrine, combinations - pseudoephedrine, combinations - for the symptomatic relief of cold, cough and nasal congestion accompanied by fever and pain, for treatment at night.

Israel - English - Ministry of Health

dexcel ltd, israel - dextromethorphan hydrobromide; guaifenesin; paracetamol; pseudoephedrine hydrochloride - caplets - paracetamol 325 mg; guaifenesin 200 mg; dextromethorphan hydrobromide 10 mg; pseudoephedrine hydrochloride 25 mg - dextromethorphan - dextromethorphan - for the symptomatic relief of cold, cough and nasal congestion accompanied by fever and pain, for day care.

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroids use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli , haemophilus influenzae, klebsiella/enter

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroids use in certain infective conjunctivides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/enteroba